Meropenem is a broad-spectrum antibiotic used to treat severe bacterial infections. However, during the manufacturing process, impurities may be formed which can affect the safety and efficacy of the drug. Meropenem impurities are unwanted substances that may be present in the drug product or intermediate. These impurities can be organic or inorganic compounds, and their presence can lead to adverse effects on patients, such as toxicity, reduced efficacy, or allergic reactions. Therefore, it is crucial to monitor and control the levels of meropenem impurities to ensure the highest quality and safety of the drug.
